Human and animal studies of bipolar, autism spectrum disorder (ASD), and schizophrenia have revealed the presence of hypermethylated RELN promoters, which correlate with a decrease in reelin protein levels [137,140,141,142]. The gene discussed is RELN; the disease is schizophrenia.